
Adaptive Phage gets $10M from DoD for antibacterial phage therapies
The company is developing phage-based therapies designed to target specific bacteria strains, as contrasted with antibiotics, which target multiple types of bacteria.
The company is developing phage-based therapies designed to target specific bacteria strains, as contrasted with antibiotics, which target multiple types of bacteria.
Recarbrio was approved for treating complex urinary tract and intra-abdominal infections among adult patients who have limited or no therapy options.
With New Enterprise Associates at the helm of the round, the company is setting out to develop antibiotics for drug-resistant bacterial infections.
Bloom Science plans to have its proprietary gut bacteria in the clinic for hard-to-treat patients in the next 12-18 months.
Dr. Anne Schuchat, the CDC's principal deputy director, said she was surprised by the extent of the spread of the bacteria, which are virtually untreatable and capable of spreading genes that make them impervious to most antibiotics.
Axial Biotherapeutics is the latest startup working to manipulate the microbiome as a means to treat disease. The Caltech spin-out just announced $19.15 million in Series A funding to tackle a range of central nervous system disorders.
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
The company is engineering microbes to treat irritable bowel syndrome, PKU and other disorders.
Microbiologist Jason Tetro explains that the best way to protect your child against allergies is to let them get dirty.
A team of Israeli researchers have developed a test that can distinguish whether an infection stems from a virus or a bacteria – a simple but potentially impactful screener that could cut down unnecessary use of antibiotics. Hailing from Israel-based biotech MeMed, the overarching goal is to curb antibiotic resistance – which is growing thanks […]
In the first genetic profile of a metropolitan transit system, Weill Cornell Medical College researcher Christopher Mason and his team spent 18 months swabbing 466 subway stations in New York City. The findings were published in the journal Cell Systems. He says in many ways the results are “a mirror of the people themselves who ride […]
Entries are flooding in for #KnitABug competition, here’s #Ecoli – Last days to enter! http://t.co/87t8HiLH2S @UKHKA pic.twitter.com/amD9iO3XgL — BBSRC (@BBSRC) October 22, 2014 Those who happen to be super into bacteria and viruses and also have a knack for knitting were in luck this year. In conjunction with the Great British Bioscience Festival, BBSRC put together Knit-a-Bug: The Great […]